L. Myasoutova

496 total citations
14 papers, 261 citations indexed

About

L. Myasoutova is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, L. Myasoutova has authored 14 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 11 papers in Immunology and 2 papers in Genetics. Recurrent topics in L. Myasoutova's work include Rheumatoid Arthritis Research and Therapies (13 papers), Spondyloarthritis Studies and Treatments (11 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). L. Myasoutova is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Spondyloarthritis Studies and Treatments (11 papers) and Psoriasis: Treatment and Pathogenesis (8 papers). L. Myasoutova collaborates with scholars based in Russia, South Korea and United States. L. Myasoutova's co-authors include Jan Lenaerts, Nathan Vastesaeger, J. Wollenhaupt, Joachim Sieper, Yeong Wook Song, Mazurov Vi, D. K. Chitkara, Martín Rudwaleit, Francisco Fidencio Cons Molina and Dae‐Hyun Yoo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

L. Myasoutova

10 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Myasoutova Russia 5 226 175 60 27 14 14 261
D Halter United States 5 302 1.3× 225 1.3× 160 2.7× 18 0.7× 7 0.5× 9 357
Maria Stefania Cutro Italy 5 186 0.8× 130 0.7× 74 1.2× 12 0.4× 14 1.0× 6 215
Helena Raffayová Slovakia 5 262 1.2× 218 1.2× 111 1.9× 5 0.2× 4 0.3× 9 309
Nikolay Stoilov Bulgaria 5 70 0.3× 39 0.2× 17 0.3× 35 1.3× 8 0.6× 27 129
J Brückel United States 6 363 1.6× 175 1.0× 134 2.2× 30 1.1× 3 0.2× 9 393
D. Ruiz Spain 7 148 0.7× 100 0.6× 44 0.7× 12 0.4× 4 0.3× 29 256
Michael Rissler Switzerland 7 166 0.7× 253 1.4× 87 1.4× 3 0.1× 9 0.6× 13 297
I. Spiller Germany 7 427 1.9× 279 1.6× 117 1.9× 44 1.6× 2 0.1× 12 470
Е. В. Зонова Russia 6 111 0.5× 62 0.4× 50 0.8× 3 0.1× 4 0.3× 21 162
D. G. Krechikova Russia 4 86 0.4× 58 0.3× 39 0.7× 3 0.1× 4 0.3× 7 115

Countries citing papers authored by L. Myasoutova

Since Specialization
Citations

This map shows the geographic impact of L. Myasoutova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Myasoutova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Myasoutova more than expected).

Fields of papers citing papers by L. Myasoutova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Myasoutova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Myasoutova. The network helps show where L. Myasoutova may publish in the future.

Co-authorship network of co-authors of L. Myasoutova

This figure shows the co-authorship network connecting the top 25 collaborators of L. Myasoutova. A scholar is included among the top collaborators of L. Myasoutova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Myasoutova. L. Myasoutova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Aringazina, Raisa, et al.. (2022). Correlation of pharmacokinetic dispositionof methotrexate and serum cytokine levels in rheumatoid arthritis patients. Bangladesh Journal of Medical Science. 21(2). 335–343. 2 indexed citations
2.
3.
4.
Myasoutova, L., et al.. (2016). AB0401 Comparative Efficacy of Injection and Tablet Methotrexate Forms in Rheumatoid Arthritis Treatment. Annals of the Rheumatic Diseases. 75. 1043–1043. 2 indexed citations
5.
Myasoutova, L., et al.. (2014). EFFECTIVENESS OF EDUCATIONAL PROGRAMS ON EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS FOR PRIMARY CARE PHYSICIANS IN KAZAN. Rheumatology Science and Practice. 52(2). 183–183.
6.
Эрдес, Ш. Ф., et al.. (2014). PROJECT OF WORKING CLASSIFICATION OF ANKYLOSING SPONDILYTIS. Rheumatology Science and Practice. 51(6). 604–604. 7 indexed citations
7.
Sieper, Joachim, Jan Lenaerts, J. Wollenhaupt, et al.. (2013). Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Annals of the Rheumatic Diseases. 73(1). 101–107. 147 indexed citations
8.
Sieper, Joachim, Jan Lenaerts, J. Wollenhaupt, et al.. (2013). Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. Annals of the Rheumatic Diseases. 73(1). 108–113. 42 indexed citations
9.
Myasoutova, L., et al.. (2013). EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS. SHILAP Revista de lepidopterología.  (1). 48–48. 1 indexed citations
10.
Sieper, J., Martín Rudwaleit, Jan Lenaerts, et al.. (2013). FRI0424 Role of baseline c-reactive protein in response to infliximab plus naproxen vs naproxen alone in patients with axial spondyloarthritis in the infast study. Annals of the Rheumatic Diseases. 72. A518–A518. 1 indexed citations
11.
12.
13.
14.
Myasoutova, L., et al.. (2011). IZMENENIYa MINERAL'NOY PLOTNOSTI KOSTNOY TKANI U BOL'NYKh ANKILOZIRUYuShchIM SPONDILOARTRITOM. SHILAP Revista de lepidopterología. 14(3). 14–18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Halter Breakdown of academic impact, for papers by Maria Stefania Cutro Breakdown of academic impact, for papers by Helena Raffayová Breakdown of academic impact, for papers by Nikolay Stoilov Breakdown of academic impact, for papers by J Brückel Breakdown of academic impact, for papers by D. Ruiz Breakdown of academic impact, for papers by Michael Rissler Breakdown of academic impact, for papers by I. Spiller Breakdown of academic impact, for papers by Е. В. Зонова Breakdown of academic impact, for papers by D. G. Krechikova
Rankless by CCL
2026